Evidence map›Paper›PMID 40807072›Full record

ReviewJournal of clinical medicine2025

From Vision to Illumination: The Promethean Journey of Optical Coherence Tomography in Cardiology.

Angela Buonpane, Giancarlo Trimarchi, Francesca Maria Di Muro, Giulia Nardi, Marco Ciardetti, Michele Alessandro Coceani, Luigi Emilio Pastormerlo, Umberto Paradossi, Sergio Berti, Carlo Trani and 7 more

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Angela BuonpaneCenter of Excellence for Cardiovascular Sciences, Isola Tiberina-Gemelli Isola Hospital, 00186 Rome, Italy.ORCID 0000-0001-8438-1004
Giancarlo TrimarchiCardiothoracic Department, Fondazione Toscana G. Monasterio, G. Pasquinucci Heart Hospital, 54100 Massa, Italy.ORCID 0009-0008-9165-7732
Francesca Maria Di MuroDepartment of Medicine, Surgery and Dentistry, University of Salerno, 84081 Salerno, Italy.
Giulia NardiDepartment of Cardiothoracic and Vascular Sciences, Careggi University Hospital, 50124 Firenze, Italy.ORCID 0000-0002-8144-0117
Marco CiardettiCardiothoracic Department, Fondazione Toscana G. Monasterio, G. Pasquinucci Heart Hospital, 54100 Massa, Italy.
Michele Alessandro CoceaniCardiothoracic Department, Fondazione Toscana G. Monasterio, G. Pasquinucci Heart Hospital, 54100 Massa, Italy.
Luigi Emilio PastormerloCardiothoracic Department, Fondazione Toscana G. Monasterio, G. Pasquinucci Heart Hospital, 54100 Massa, Italy.
Umberto ParadossiCardiothoracic Department, Fondazione Toscana G. Monasterio, G. Pasquinucci Heart Hospital, 54100 Massa, Italy.ORCID 0000-0002-4100-4732
Sergio BertiCardiothoracic Department, Fondazione Toscana G. Monasterio, G. Pasquinucci Heart Hospital, 54100 Massa, Italy.ORCID 0000-0002-5244-0556
Carlo TraniDepartment of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli, Scientific Institute for Research, Hospitalization and Healthcare, Università Cattolica Sacro Cuore, 00168 Rome, Italy.
Giovanna LiuzzoDepartment of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli, Scientific Institute for Research, Hospitalization and Healthcare, Università Cattolica Sacro Cuore, 00168 Rome, Italy.
Italo PortoScientific Institute for Research, Hospitalization and Healthcare, Ospedale Policlinico San Martino, Università di Genova, 16162 Genoa, Italy.ORCID 0000-0002-9854-5046
Antonio Maria LeoneCenter of Excellence for Cardiovascular Sciences, Isola Tiberina-Gemelli Isola Hospital, 00186 Rome, Italy.ORCID 0000-0002-1276-9883
Filippo CreaCenter of Excellence for Cardiovascular Sciences, Isola Tiberina-Gemelli Isola Hospital, 00186 Rome, Italy.
Francesco BurzottaDepartment of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli, Scientific Institute for Research, Hospitalization and Healthcare, Università Cattolica Sacro Cuore, 00168 Rome, Italy.ORCID 0000-0002-6569-9401
Rocco VergalloScientific Institute for Research, Hospitalization and Healthcare, Ospedale Policlinico San Martino, Università di Genova, 16162 Genoa, Italy.
Alberto Ranieri De CaterinaCardiothoracic Department, Fondazione Toscana G. Monasterio, G. Pasquinucci Heart Hospital, 54100 Massa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optical Coherence Tomography (OCT) has evolved from a breakthrough ophthalmologic imaging tool into a cornerstone technology in interventional cardiology. After its initial applications in retinal imaging in the early 1990s, OCT was subsequently envisioned for cardiovascular use. In 1995, its ability to visualize atherosclerotic plaques was demonstrated in an in vitro study, and the following year marked the acquisition of the first in vivo OCT image of a human coronary artery. A major milestone followed in 2000, with the first intracoronary imaging in a living patient using time-domain OCT. However, the real inflection point came in 2006 with the advent of frequency-domain OCT, which dramatically improved acquisition speed and image quality, enabling safe and routine imaging in the catheterization lab. With the advent of high-resolution, second-generation frequency-domain systems, OCT has become clinically practical and widely adopted in catheterization laboratories. OCT progressively entered interventional cardiology, first proving its safety and feasibility, then demonstrating superiority over angiography alone in guiding percutaneous coronary interventions and improving outcomes. Today, it plays a central role not only in clinical practice but also in cardiovascular research, enabling precise assessment of plaque biology and response to therapy. With the advent of artificial intelligence and hybrid imaging systems, OCT is now evolving into a true precision-medicine tool-one that not only guides today's therapies but also opens new frontiers for discovery, with vast potential still waiting to be explored. Tracing its historical evolution from ophthalmology to cardiology, this narrative review highlights the key technological milestones, clinical insights, and future perspectives that position OCT as an indispensable modality in contemporary interventional cardiology. As a guiding thread, the myth of Prometheus is used to symbolize the evolution of OCT-from its illuminating beginnings in ophthalmology to its transformative role in cardiology-as a metaphor for how light, innovation, and knowledge can reveal what was once hidden and redefine clinical practice.

Indexed as

coronary artery diseaseintravascular imagingOptical Coherence Tomography

Identifiers

PMID40807072
PMCPMC12346916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.